|
Eskalith CrDrug - Eskalith Cr The trade name of the product as shown on the labeling.
Dosage -
TABLET, EXTENDED RELEASE; ORAL
Active Ingredient(s) -
Lithium Carbonate
Strength -
450MG
Applicant -
GLAXOSMITHKLINE
New Drug Application (NDA) Number -
018152
Product Number -
001
Therapeutic Equivalence (TE) Code -
AB
Approval Date -
Mar 29, 1982
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Glaxosmithkline
Eskalith Cr
Lithonate 300mg Capsule; Oral
Eskalith Cr 450mg Tablet, Extended Release; Oral Lithium Carbonate 300mg Capsule; Oral Lithium Carbonate 150mg Capsule; Oral Lithium Carbonate 300mg Capsule; Oral Lithium Carbonate 600mg Capsule; Oral Lithium Carbonate 300mg Capsule; Oral Lithium Carbonate 300mg Capsule; Oral Lithium Carbonate 150mg Capsule; Oral Lithium Carbonate 300mg Capsule; Oral NewDrugInformation |